When examining the level of FABP3 expression in embryonic tumor cells, breast cancer cells [68], and FABP4 in breast, ovarian, prostate, bladder or liver cancer cells, low levels of both proteins were observed, which was associated with a worse prognosis in terms of overall survival. This evidence concerns the gene FABP3 and neoplasm.